Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo. 1985

A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo

The aim of this study was to evaluate the in vitro effects of verapamil on platelet aggregation and serum thromboxane formation. We also studied the in vivo effects of verapamil retard on platelet aggregation and serum thromboxane formation. The incubation of verapamil with PRP produced a dose-dependent decrease of in vitro platelet aggregation for all the agents used. Potentiation by verapamil of antiaggregating activity of prostacyclin was also demonstrated; in fact when verapamil and prostacyclin were added simultaneously a synergistic inhibition of platelet aggregation by ADP was observed. In whole blood verapamil partially inhibited thromboxane production only at a higher concentration. In vivo verapamil significantly decreased platelet aggregation induced by ADP and epinephrine while no changes were observed after arachidonic acid. No significant changes occurred in serum TXB2 levels. The observations suggest a potential role for verapamil in antithrombotic therapy as an antiplatelet agent.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
June 1983, Thrombosis research,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
February 2008, The Journal of antimicrobial chemotherapy,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
April 1985, Thrombosis research,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
June 1979, Prostaglandins and medicine,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
January 1983, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
February 1985, Thrombosis research,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
January 1986, Anticancer research,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
January 1987, Haemostasis,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
March 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
A Strano, and G Davì, and S Novo, and N Custro, and A Mattina, and V Gallo
January 1983, Haematologica,
Copied contents to your clipboard!